Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Medication Adherence and Discontinuation Among Patients With Prostate Cancer Who Initiated Second Generation Androgen Receptor Inhibitors

NCT05202301 is registered in ClinicalTrials.gov with Bayer as lead sponsor.

NCT NCT05202301
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05202301 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Medication Adherence and Discontinuation Among Patients With Prostate Cancer Who Initiated Second Generation Androgen Receptor Inhibitors
Lead sponsor
Bayer
Phase
Observational
Overall status
Completed
Start date
January 15, 2022
Completion date
July 15, 2025
Enrollment
13,779 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

prostate cancer